1 Min(s) Read
By Reuters Dec 31, 2022 8:52:19 PM IST (Published)
India’s Health Minister, Mansukh Mandaviya, asked pharma companies and senior government officials to review availability of medicines, and monitor their stocks and prices in a meeting on Thursday to ensure domestic availability for any COVID-19 surges, a source familiar with the matter said.
India’s Ministry of Commerce has been asked to monitor exports of medicinal products and equipment to China to ensure domestic availability for any COVID-19 surges, according to a source familiar with the matter.
India’s Health Minister, Mansukh Mandaviya, asked pharma companies and senior government officials to review availability of medicines, and monitor their stocks and prices in a meeting on Thursday, the source told Reuters.